Advertisement
Screener

Neurogene Inc. (NGNE) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

Neurogene Inc. Stock-Based Compensation

Neurogene Inc. (NGNE) reported Stock-Based Compensation of $11.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-11

  • Neurogene Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $7.86M, a 130.69% increase year-over-year.
  • Neurogene Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $3.63M, a 10.35% decline year-over-year.
  • Neurogene Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $3.36M, a 35.18% increase year-over-year.
  • Neurogene Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $3.37M, a 36.01% increase year-over-year.
  • Neurogene Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $14.18M, a 70.47% increase from fiscal 2024.
  • Neurogene Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $8.32M, a 486.74% increase from fiscal 2023.
  • Neurogene Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $1.42M, a 13.26% increase from fiscal 2022.
  • Neurogene Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $1.25M, a 89.17% decline from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filedShare-based Payment Arrangement, Noncash Expense 123 month
2026-06-30$7.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
$11.49M
10-Q · filed 2026-08-11
$14.85M
derived: sum of 3 quarters · filed 2026-08-11
$18.22M
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31$3.63M
10-Q · filed 2026-05-12
$6.99M
derived: sum of 2 quarters · filed 2026-05-12
$10.36M
derived: sum of 3 quarters · filed 2026-05-12
$13.76M
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31$3.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
$6.73M
derived: sum of 2 quarters · filed 2026-03-24
$10.13M
derived: sum of 3 quarters · filed 2026-08-11
$14.18M
10-K · filed 2026-03-24
2025-09-30$3.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$6.77M
derived: sum of 2 quarters · filed 2026-08-11
$10.82M
10-Q · filed 2025-11-13
$13.31M
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30$3.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
$7.46M
10-Q · filed 2026-08-11
$9.94M
derived: sum of 3 quarters · filed 2026-08-11
$12.42M
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31$4.05M
10-Q · filed 2026-05-12
$6.54M
derived: sum of 2 quarters · filed 2026-05-12
$9.01M
derived: sum of 3 quarters · filed 2026-05-12
$11.32M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$2.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
$4.96M
derived: sum of 2 quarters · filed 2026-03-24
$7.28M
derived: sum of 3 quarters · filed 2026-03-24
$8.32M
10-K · filed 2026-03-24
2024-09-30$2.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$4.79M
derived: sum of 2 quarters · filed 2025-11-13
$5.83M
10-Q · filed 2025-11-13
$6.19M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$2.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
$3.36M
10-Q · filed 2025-08-11
$3.71M
derived: sum of 3 quarters · filed 2025-08-11
$4.10M
derived: sum of 4 quarters · filed 2025-08-11
2024-03-31$1.04M
10-Q · filed 2025-05-09
$1.40M
derived: sum of 2 quarters · filed 2025-05-09
$1.79M
derived: sum of 3 quarters · filed 2025-05-09
$2.17M
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31$355.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
$741.00K
derived: sum of 2 quarters · filed 2025-03-24
$1.13M
derived: sum of 3 quarters · filed 2025-03-24
$1.42M
10-K · filed 2025-03-24
2023-09-30$386.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18
$770.00K
derived: sum of 2 quarters · filed 2024-11-18
$1.06M
10-Q · filed 2024-11-18
$1.69M
10-Q · filed 2023-11-14
-$4.47M
derived: sum of 4 quarters · filed 2024-11-18
2023-06-30$384.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$677.00K
10-Q · filed 2024-08-09
$1.52M
10-Q · filed 2023-08-10
-$4.86M
derived: sum of 3 quarters · filed 2024-08-09
-$2.83M
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31$293.00K
10-Q · filed 2024-05-10
$1.19M
10-Q · filed 2023-05-08
-$5.24M
derived: sum of 2 quarters · filed 2024-05-10
-$3.21M
derived: sum of 3 quarters · filed 2024-05-10
-$901.00K
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31-$5.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18
-$3.51M
derived: sum of 2 quarters · filed 2024-03-18
-$1.19M
derived: sum of 3 quarters · filed 2024-03-18
$1.25M
10-K · filed 2024-03-18
$8.83M
10-K · filed 2023-03-20
2022-09-30$2.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$4.34M
derived: sum of 2 quarters · filed 2023-11-14
$6.79M
10-Q · filed 2023-11-14
$9.80M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$2.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$4.76M
10-Q · filed 2023-08-10
$7.77M
derived: sum of 3 quarters · filed 2023-08-10
$10.98M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$2.45M
10-Q · filed 2023-05-08
$5.46M
derived: sum of 2 quarters · filed 2023-05-08
$8.66M
derived: sum of 3 quarters · filed 2023-05-08
$11.58M
derived: sum of 4 quarters · filed 2023-05-08
2021-12-31$3.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20
$6.22M
derived: sum of 2 quarters · filed 2023-03-20
$9.14M
derived: sum of 3 quarters · filed 2023-03-20
$11.56M
10-K · filed 2023-03-20
2021-09-30$3.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$6.13M
derived: sum of 2 quarters · filed 2022-11-14
$8.55M
10-Q · filed 2022-11-14
$10.78M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$2.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$5.34M
10-Q · filed 2022-08-09
$7.57M
derived: sum of 3 quarters · filed 2022-08-09
$9.26M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$2.42M
10-Q · filed 2022-05-09
$4.65M
derived: sum of 2 quarters · filed 2022-05-09
$6.34M
derived: sum of 3 quarters · filed 2022-05-09
$7.36M
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31$2.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$3.92M
derived: sum of 2 quarters · filed 2022-03-01
$4.94M
derived: sum of 3 quarters · filed 2022-03-01
$5.62M
10-K · filed 2022-03-01
2020-09-30$1.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$2.71M
derived: sum of 2 quarters · filed 2021-11-04
$3.39M
10-Q · filed 2021-11-04
$4.06M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$1.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$1.71M
10-Q · filed 2021-08-05
$2.37M
derived: sum of 3 quarters · filed 2021-08-05
$7.52M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31$683.00K
10-Q · filed 2021-05-12
$1.35M
derived: sum of 2 quarters · filed 2021-05-12
$6.50M
derived: sum of 3 quarters · filed 2021-05-12
$7.29M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$666.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
$5.82M
derived: sum of 2 quarters · filed 2021-03-25
$6.61M
derived: sum of 3 quarters · filed 2021-03-25
$7.68M
10-K · filed 2021-03-25
2019-09-30$5.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$5.94M
derived: sum of 2 quarters · filed 2020-11-09
$7.02M
10-Q · filed 2020-11-09
$7.85M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$788.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
$1.87M
10-Q · filed 2020-08-12
$2.70M
derived: sum of 3 quarters · filed 2020-08-12
$3.74M
derived: sum of 4 quarters · filed 2020-08-12
2019-03-31$1.08M
10-Q · filed 2020-05-06
$1.92M
derived: sum of 2 quarters · filed 2020-05-06
$2.95M
derived: sum of 3 quarters · filed 2020-05-06
$4.46M
derived: sum of 4 quarters · filed 2020-05-06
2018-12-31$837.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$1.87M
derived: sum of 2 quarters · filed 2020-03-12
$3.39M
derived: sum of 3 quarters · filed 2020-03-12
$4.70M
10-K · filed 2020-03-12
2018-09-30$1.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
$2.55M
derived: sum of 2 quarters · filed 2019-11-13
$3.86M
10-Q · filed 2019-11-13
$4.83M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30$1.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$2.83M
10-Q · filed 2019-08-01
$3.80M
derived: sum of 3 quarters · filed 2020-03-12
$4.98M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31$1.31M
10-Q · filed 2019-05-07
$2.28M
derived: sum of 2 quarters · filed 2020-03-12
$3.47M
derived: sum of 3 quarters · filed 2020-03-12
$4.52M
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31$971.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$2.15M
derived: sum of 2 quarters · filed 2020-03-12
$3.21M
derived: sum of 3 quarters · filed 2020-03-12
$3.84M
10-K · filed 2020-03-12
2017-09-30$1.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$2.24M
derived: sum of 2 quarters · filed 2018-11-07
$2.87M
10-Q · filed 2018-11-07
$3.43M
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30$1.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
$1.69M
10-Q · filed 2018-08-08
$2.25M
derived: sum of 3 quarters · filed 2019-03-07
$2.74M
derived: sum of 4 quarters · filed 2019-03-07
2017-03-31$631.00K
10-Q · filed 2018-05-08
$1.19M
derived: sum of 2 quarters · filed 2019-03-07
$1.68M
derived: sum of 3 quarters · filed 2019-03-07
$2.16M
derived: sum of 4 quarters · filed 2019-03-07
2016-12-31$561.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$1.05M
derived: sum of 2 quarters · filed 2019-03-07
$1.53M
derived: sum of 3 quarters · filed 2019-03-07
$1.97M
10-K · filed 2019-03-07
2016-09-30$490.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$972.00K
derived: sum of 2 quarters · filed 2017-11-08
$1.41M
10-Q · filed 2017-11-08
$1.77M
derived: sum of 4 quarters · filed 2018-03-12
2016-06-30$482.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$915.00K
10-Q · filed 2017-08-08
$1.28M
derived: sum of 3 quarters · filed 2018-03-12
$1.70M
derived: sum of 4 quarters · filed 2018-03-12
2016-03-31$433.00K
10-Q · filed 2017-05-09
$794.00K
derived: sum of 2 quarters · filed 2018-03-12
$1.22M
derived: sum of 3 quarters · filed 2018-03-12
$1.67M
derived: sum of 4 quarters · filed 2018-03-12
2015-12-31$361.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
$785.00K
derived: sum of 2 quarters · filed 2018-03-12
$1.24M
derived: sum of 3 quarters · filed 2018-03-12
$1.51M
10-K · filed 2018-03-12
2015-09-30$424.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$879.00K
derived: sum of 2 quarters · filed 2016-11-09
$1.15M
10-Q · filed 2016-11-09
$1.41M
derived: sum of 4 quarters · filed 2017-03-09
2015-06-30$455.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$721.00K
10-Q · filed 2016-08-04
$990.00K
derived: sum of 3 quarters · filed 2017-03-09
$1.22M
derived: sum of 4 quarters · filed 2017-03-09
2015-03-31$266.00K
10-Q · filed 2016-05-10
$535.00K
derived: sum of 2 quarters · filed 2017-03-09
$767.63K
derived: sum of 3 quarters · filed 2017-03-09
$982.46K
derived: sum of 4 quarters · filed 2017-03-09
2014-12-31$269.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$501.63K
derived: sum of 2 quarters · filed 2017-03-09
$716.46K
derived: sum of 3 quarters · filed 2017-03-09
$854.00K
10-K · filed 2017-03-09
$854.19K
10-K · filed 2015-03-16
2014-09-30$232.63K
10-Q · filed 2014-11-04
$447.46K
derived: sum of 2 quarters · filed 2014-11-04
$585.00K
10-Q · filed 2015-11-10
$585.11K
10-Q · filed 2014-11-04
$679.14K
derived: sum of 4 quarters · filed 2016-03-14
2014-06-30$214.82K
10-Q · filed 2014-08-11
$352.00K
10-Q · filed 2015-08-06
$352.48K
10-Q · filed 2014-08-11
$446.50K
derived: sum of 3 quarters · filed 2016-03-14
$573.66K
derived: sum of 4 quarters · filed 2016-03-14
2014-03-31$138.00K
10-Q · filed 2015-05-12
$137.65K
10-Q · filed 2014-05-13
$231.68K
derived: sum of 2 quarters · filed 2016-03-14
$358.84K
derived: sum of 3 quarters · filed 2016-03-14
$432.33K
derived: sum of 4 quarters · filed 2016-03-14
$1.41M
10-Q · filed 2014-05-13
2013-12-31$93.68K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
$220.84K
derived: sum of 2 quarters · filed 2016-03-14
$294.33K
derived: sum of 3 quarters · filed 2016-03-14
$349.00K
10-K · filed 2016-03-14
$349.32K
10-K · filed 2015-03-16
2013-09-30$127.16K
10-Q · filed 2014-11-04
$200.64K
derived: sum of 2 quarters · filed 2014-11-04
$255.32K
10-Q · filed 2014-11-04
2013-06-30$73.48K
10-Q · filed 2014-08-11
$128.16K
10-Q · filed 2014-08-11
2013-03-31$54.67K
10-Q · filed 2014-05-13
2012-12-31$351.32K
10-K · filed 2015-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
CorMedix Inc. (CRMD)United States$0.605B3.25
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Monopar Therapeutics (MNPR)United States$0.598B-34.82
Altimmune, Inc. (ALT)United States$0.593B-6.43
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76